Medical device company DexCom (NASDAQ:DXCM) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 12.5% year on ...

DexCom, Inc. DXCM is well-poised for growth in the coming quarters, backed by its strong product portfolio. A strong ...

In this article, we are going to take a look at where DexCom, Inc. (NASDAQ:DXCM) stands against the other diabetes stocks. According to the WHO, approximately 422 million individuals globally ...

Key Insights DexCom's estimated fair value is US$116 based on 2 Stage Free Cash Flow to Equity DexCom is estimated ...

DXCM Finanicals Stock Screener Earnings Calendar Sectors Nasdaq Search Ticker | DXCM U.S.: Nasdaq DexCom Inc. + Watchlist Alert DXCM US Open Last Updated: May 23, 2025 12:17 p.m. EDT Real time ...

DexCom (NASDAQ:DXCM) stock saw a notable increase of 16% on Friday following the announcement of its Q1 earnings and a share buyback program. The company’s first-quarter sales hit $1.04 billion ...

DexCom, Inc. DXCM is well poised for growth in the coming quarters, backed by its strong product portfolio. A robust third-quarter 2023 performance, along with a series of favorable coverage ...

Shares of DexCom Inc. DXCM shed 1.11% to $84.11 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index SPX rising 0.72% to 5,886.55 and the Dow ...

We believe DexCom stock (NASDAQ NDAQ: DXCM) is currently a better pick than Abbott stock (NYSE: ABT), given its better prospects. Although Abbott is trading at a comparatively lower valuation of 3 ...